BiotechTube
Home/Botanix Pharmaceuticals/Danny Sharp
DS

Danny Sharp

Non-Executive Director

Botanix Pharmaceuticals

Therapeutic Areas

DermatologyAnti-infectives

Botanix Pharmaceuticals Pipeline

DrugIndicationPhase
Sofdra™ (sofpironium) topical gel, 12.45%Primary Axillary HyperhidrosisApproved
BTX 1503AcnePhase 2
BTX 1702Papulopustular RosaceaPreclinical
BTX 1204ACanine Atopic Dermatitis (Human potential)Veterinary Pilot
BTX 1801S. aureus / MRSA DecolonizationPreclinical

Leadership Team at Botanix Pharmaceuticals

VI
Vince Ippolito
Executive Chairman
DH
Dr. Howie McKibbon
Chief Executive Officer
DS
Dr. Stewart Washer
Director
DB
Dr. Bill Bosch
Non-Executive Director
DP
Dr. Patricia Walker
Non-Executive Director
View full Botanix Pharmaceuticals profile